| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6094004 | Gastroenterology | 2014 | 12 Pages |
Abstract
About 25% of patients with stages II-III colorectal tumors with MSI have an excellent response to chemotherapy, due to large, biallelic deletions in the T17 intron repeat of HSP110 in tumor DNA.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Ada Collura, Anaïs Lagrange, Magali Svrcek, Laetitia Marisa, Olivier Buhard, Agathe Guilloux, Kristell Wanherdrick, Coralie Dorard, Anna Taieb, Arnaud Saget, Marie Loh, Richie Soong, Nikolajs Zeps, Cameron Platell, Andrew Mews, Barry Iacopetta,